3.5K(top 0.1%)
221.4K(top 0.1%)
201(top 0.1%)
363(top 0.1%)
all documents
doc citations
citing journals

Top Articles

1Operating characteristics of a rank correlation test for publication biasBiometrics19945,751
2Assessing the Performance of Prediction ModelsEpidemiology20103,387
3Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making20063,292
4Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA - Journal of the American Medical Association19962,883
5Tumor mutational load predicts survival after immunotherapy across multiple cancer typesNature Genetics20192,702
6Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsNew England Journal of Medicine20122,553
7Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsNature Medicine20172,473
8How To Build and Interpret a Nomogram for Cancer PrognosisJournal of Clinical Oncology20082,273
9Nomograms in oncology: more than meets the eyeLancet Oncology, The20152,187
10Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine20142,069
11Circular binary segmentation for the analysis of array-based DNA copy number dataBiostatistics20041,903
12Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerCell20181,718
13Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer20101,691
14Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort studyLancet Oncology, The20061,456
15Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejectionNature20171,314
16The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEuropean Journal of Cancer19941,301
17T-cell invigoration to tumour burden ratio associated with anti-PD-1 responseNature20171,280
18Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemiasBlood20111,135
19Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markersBMC Medical Informatics and Decision Making2008966
20Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine1999944
21A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell2012913
22Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology Biology Physics1998876
23Primary Care Physicians Who Treat Blacks and WhitesNew England Journal of Medicine2004865
24Genomic correlates of clinical outcome in advanced prostate cancerProceedings of the National Academy of Sciences of the United States of America2019839
25Acupuncture for Chronic PainArchives of Internal Medicine2012835
26FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencingNucleic Acids Research2016809
27A faster circular binary segmentation algorithm for the analysis of array CGH dataBioinformatics2007805
28Variations in Morbidity after Radical ProstatectomyNew England Journal of Medicine2002800
29Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesGenome Biology2016746
30Eleven grand challenges in single-cell data scienceGenome Biology2020742
31High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology Biology Physics2002727
32Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics2012692
33Increasing value and reducing waste: addressing inaccessible researchLancet, The2014692
34Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate CancerJournal of Clinical Oncology1999686
35Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysisBioinformatics2009671
36Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of TherapyJournal of Clinical Oncology1999658
37The Influence of Hospital Volume on Survival after Resection for Lung CancerNew England Journal of Medicine2001656
38Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificityNature Biotechnology2016634
39The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersCancer Cell2018633
40A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorderMolecular Psychiatry2008619
41A note on competing risks in survival data analysisBritish Journal of Cancer2004598
42Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerNature Genetics2009597
43Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaCancer Discovery2018594
44Reporting and Interpreting Decision Curve Analysis: A Guide for InvestigatorsEuropean Urology2018590
45Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)JAMA Oncology2015581
46Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCell Stem Cell2017578
47Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic testsBMJ, The2016577
48Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerNature Medicine2016572
49Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoNature Biotechnology2018564
50Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataLancet Oncology, The2009558